TY - JOUR
T1 - Clinical importance of incidental homogeneous renal masses that measure 10-40 mm and 21-39 HU at portal venous phase CT
T2 - A 12-institution retrospective cohort study
AU - Corwin, Michael T.
AU - Altinmakas, Emre
AU - Asch, Daniella
AU - Bishop, Kristen A.
AU - Boge, Medine
AU - Curci, Nicole E.
AU - Ebada, Mohamed
AU - Elkassem, Asser Abou
AU - Fananapazir, Ghaneh
AU - Fetzer, David T.
AU - Gaballah, Ayman H.
AU - Gandhi, Darshan
AU - Kampalath, Rony
AU - Lee, Sonia
AU - Markese, Matt
AU - McInnes, Matthew D.F.
AU - Patel, Nayana U.
AU - Remer, Erick M.
AU - Rosasco, Sarah
AU - Schieda, Nicola
AU - Sweet, David E.
AU - Smith, Andrew D.
AU - Taylor, Erin
AU - Silverman, Stuart G.
AU - Davenport, Matthew S.
N1 - Publisher Copyright:
© American Roentgen Ray Society
PY - 2021/6
Y1 - 2021/6
N2 - BACKGROUND. Incidental homogeneous renal masses are frequently encountered at portal venous phase CT. The American College of Radiology Incidental Findings Committee's white paper on renal masses recommends additional imaging for incidental homogeneous renal masses greater than 20 HU, but single-center data and the Bosniak classification version 2019 suggest the optimal attenuation threshold for detecting solid masses should be higher. OBJECTIVE. The purpose of this article is to determine the clinical importance of small (10-40 mm) incidentally detected homogeneous renal masses measuring 21-39 HU at portal venous phase CT. METHODS. We performed a 12-institution retrospective cohort study of adult patients who underwent portal venous phase CT for a nonrenal indication. The date of the first CT at each institution ranged from January 1, 2008, to January 1, 2014. Consecutive reports from 12,167 portal venous phase CT examinations were evaluated. Images were reviewed for 4529 CT examinations whose report described a focal renal mass. Eligible masses were 10-40 mm, well-defined, subjectively homogeneous, and 21-39 HU. Of these, masses that were shown to be solid without macroscopic fat; classified as Bosniak IIF, III, or IV; or confirmed to be malignant were considered clinically important. The reference standard was renal mass protocol CT or MRI, ultrasound of definitively benign cysts or solid masses, single-phase contrast-enhanced CT or unenhanced MRI showing no growth or morphologic change for 5 years or more, or clinical follow-up 5 years or greater. A reference standard was available for 346 masses in 300 patients. The 95% CIs were calculated using the binomial exact method. RESULTS. Eligible masses were identified in 4.2% of patients (514/12,167; 95% CI, 3.9-4.6%). Of 346 masses with a reference standard, none were clinically important (0%; 95% CI, 0-0.9%). Mean mass size was 17 mm; 72% (248/346) measured 21-30 HU, and 28% (98/346) measured 31-39 HU. CONCLUSION. Incidental small homogeneous renal masses measuring 21-39 HU at portal venous phase CT are common and highly likely benign. CLINICAL IMPACT. The change in attenuation threshold signifying the need for additional imaging from greater than 20 HU to greater than 30 HU proposed by the Bosniak classification version 2019 is supported.
AB - BACKGROUND. Incidental homogeneous renal masses are frequently encountered at portal venous phase CT. The American College of Radiology Incidental Findings Committee's white paper on renal masses recommends additional imaging for incidental homogeneous renal masses greater than 20 HU, but single-center data and the Bosniak classification version 2019 suggest the optimal attenuation threshold for detecting solid masses should be higher. OBJECTIVE. The purpose of this article is to determine the clinical importance of small (10-40 mm) incidentally detected homogeneous renal masses measuring 21-39 HU at portal venous phase CT. METHODS. We performed a 12-institution retrospective cohort study of adult patients who underwent portal venous phase CT for a nonrenal indication. The date of the first CT at each institution ranged from January 1, 2008, to January 1, 2014. Consecutive reports from 12,167 portal venous phase CT examinations were evaluated. Images were reviewed for 4529 CT examinations whose report described a focal renal mass. Eligible masses were 10-40 mm, well-defined, subjectively homogeneous, and 21-39 HU. Of these, masses that were shown to be solid without macroscopic fat; classified as Bosniak IIF, III, or IV; or confirmed to be malignant were considered clinically important. The reference standard was renal mass protocol CT or MRI, ultrasound of definitively benign cysts or solid masses, single-phase contrast-enhanced CT or unenhanced MRI showing no growth or morphologic change for 5 years or more, or clinical follow-up 5 years or greater. A reference standard was available for 346 masses in 300 patients. The 95% CIs were calculated using the binomial exact method. RESULTS. Eligible masses were identified in 4.2% of patients (514/12,167; 95% CI, 3.9-4.6%). Of 346 masses with a reference standard, none were clinically important (0%; 95% CI, 0-0.9%). Mean mass size was 17 mm; 72% (248/346) measured 21-30 HU, and 28% (98/346) measured 31-39 HU. CONCLUSION. Incidental small homogeneous renal masses measuring 21-39 HU at portal venous phase CT are common and highly likely benign. CLINICAL IMPACT. The change in attenuation threshold signifying the need for additional imaging from greater than 20 HU to greater than 30 HU proposed by the Bosniak classification version 2019 is supported.
KW - Incidental
KW - Indeterminate
KW - Portal venous phase
KW - Renal mass
UR - http://www.scopus.com/inward/record.url?scp=85108528322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108528322&partnerID=8YFLogxK
U2 - 10.2214/AJR.20.24245
DO - 10.2214/AJR.20.24245
M3 - Article
C2 - 32845714
AN - SCOPUS:85108528322
SN - 0361-803X
VL - 217
SP - 135
EP - 140
JO - American Journal of Roentgenology
JF - American Journal of Roentgenology
IS - 1
ER -